Providing women with hormone insights to understand and act upon their health, Inne raises $10 million
Summary
The health tech startup produces a saliva biosensor mini-lab that can be used by women to track progesterone levels within their bodies.Already in use by thousands of customers across Europe, Innes new $10 million raise will specifically aid the company to expand the platform and enter the US market through an exclusive partnership with Phenology. The one were perhaps most familiar with is progesterones role in the sex hormone involved in the menstrual cycle, and pregnancy cycle of mammals.However, progesterone doesnt stop there, as it also plays a crucial role in the production of other steroids, least of which is the corticosteroid, a duality steroid (gluco or mineralo) which is involved in the actions of stress response, immune response, regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior.Becoming a certified medical device in 2019, Innes mini lab has been proven to be as accurate as if users in Germany, Switzerland, Austria, and the UK had shipped a sample off to a full-blown dedicated lab, and gleaned a more precise picture of their menstrual cycle.According to the startup, some users have used the service to help them get pregnant, while others have done just the opposite. To this end, Inne is currently in the process of achieving certification as a contraceptive product following the results of ongoing clinical studies.In addition to extending its services to the tracking of perimenopause, the new capital will be used to roll out stress tracking/analysing features through a dedicated cortisol strip. This information gap has been a driving force for me in creating inne and Im thrilled that we are now able to help women learn about their bodies and be proactive in managing their own health and fertility, commented Inne founder and CEO Eirini Rapti.Innes $10 million Series A extension round was led by DSM Venturing, with Borski Fund, Calm Storm Ventures, and angel investors Taavet Hinrikus (Wise), Dr. Fiona Pathiraja, and Rolf Schroemgens (Trivago) all participating.The product is best in class for in-home testing of hormone levels. We are enthusiastic because of the multiple use cases, from fertility to contraception and perimenopause, concluded Borski Funds Simone Brummelhuis.